Great result. $20mil buy back is certainly welcome and lets the market know that management see value in the shares. All financial metrics and forward guidance looks strong
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025